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Identity 
Other names: COCA2; FCC2; hMLH1; HNPCC2 
HGNC (Hugo): MLH1 
Location: 3p21.3 




The MLH1 gene is composed of 19 exons spanning in a 
region of 57360 bp. 
Transcription 
The transcribed mRNA has 2524 bp. 
 
Diagram of the MLH1 gene. Exons are represented by boxes (in scale) transcribed and untranscribed sequences in blue and yellow, with 
exon numbers on top and number of base pairs at the bottom. Introns are represented by black bars (not in scale) and the number of 
base pairs indicated. The arrows show the ATG and the stop codons respectively. 
 
Diagram of the MLH1 protein in scale. Numbers inside the blue boxes indicate the exon from which is translated each part of the protein. 
The three boxes inside represent the ATPase domain, the MutS homologs interaction domain and the PMS2/MLH3/PMS1 interaction 
domain; C: Carboxyl-terminal; N: Amino-terminal 
 
 











Aminoacids: 756. Molecular Weight: 84.6 kDa. MLH1 
is a protein involved in the mismatch repair process 
after DNA replication. It contains an ATPase domain 
and two interaction domains, one for MutS homologs 
(MSH2, MSH3, MSH6) and the other for PMS2, 




MLH1 has no known enzymatic activity. MLH1 forms 
a heterodimer with PMS2 known as MutLa, although it 
can also bind to PMS1 or MLH3. This heterodimeric 
complex binds to the heteroduplexes MutSa (composed 
of MSH2 and MSH6) or MutSb (composed of MSH2 
and MSH3), which recognize DNA lesions. The 
heterodimer formed by MLH1 is responsible for the 
recruitment of the proteins needed for the excision and 
repair synthesis. 
Homology 
MLH1 is homologue to the bacterial MutL gene, 
specially in the N-terminal region, and MLH1 
homologues are also present in eukaryotes (for example 
in Mus musculus, Drosophila melanogaster, 
Caenorhabditis elegans or Saccharomyces cerevisae). 
Mutations 
Germinal 
There are over 300 MLH1 germline mutations 
described all along the gene that cause hereditary non-
polyposis colorectal cancer (HNPCC, see below). 
These mutations are not present in any particular 
hotspot or zone of the gene and include either 
nucleotide substitutions (missense, nonsense or splicing 
errors) or insertions/deletions (gross or small). In most 
of these mutations the resulting protein is truncated.  
There are also founding mutations which account for a 
high proportion of the HNPCC tumours in some 
specific populations (for example there are two Finnish 
mutations that delete the exons 16 or 6). Some germline 
genetic changes have also been described in both exons 
and introns as non pathogenic. 
Somatic 
There are described some sporadic mismatch repair 
deficiency cases (sporadic MSI) with somatic MLH1 







HNPCC (Hereditary Non Polyposis 
Colorectal Cancer) 
Disease 
Predisposition to develop cancer, preferentially 
colorectal, but also in endometrium, ovary, urinary 
tract, stomach, small bowel, biliary tract and brain. 
Oncogenesis 
MLH1 mutations in HNPCC account for about 25% of 
the total cases approximately. These mutations are 
inherited in one allele and later the other allele is lost 
by LOH. This leads to mismatch repair deficiency in 
these patients, which is the cause of the accumulation 
of mutations along the genome, causing microsatellite 
instability (MSI) and promoting tumorigenesis. It has 
been suggested that low levels of MSI characterize 
MLH1 and MSH2 HNPCC carriers before tumor 
diagnosis. 
MSI (MicroSatellite Instability) 
Note 
Tumours in which the molecular feature that leads to 
cancer is the lost of the mismatch repair (MMR) 
system. 
Disease 
This phenotype is present in 15% of colorectal, gastric 
and endometrial cancer, and with lower incidence in 
some other tissues. 
Prognosis 
MSI tumours have better prognosis than the 
MicroSatellite Stable (MSS). 
Oncogenesis 
Sporadic MSI cases are mostly due to a biallelic 
hypermetilation of the MLH1 promotor and therefore 
lack of MLH1 protein expression. Few sporadic cases 
and about 25% of the HNPCC are due to different 




Coincidence of at least one sebaceous adenoma, 
epithelioma or carcinoma and one internal malignancy. 
Oncogenesis 
Inherited MLH1 mutations can cause Muir-Torre 
syndrome (although MSH2 mutations are more 
present). 
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